Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases.

MLA

Gallego, Idoia, et al. “Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases.” Molecular Pharmaceutics, vol. 17, no. 6, June 2020, pp. 1848–58. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.9b01213.

APA

Gallego, I., Villate-Beitia, I., Soto-Sánchez, C., Menéndez, M., Grijalvo, S., Eritja, R., Martínez-Navarrete, G., Humphreys, L., López-Méndez, T., Puras, G., Fernández, E., & Pedraz, J. L. (2020). Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases. Molecular Pharmaceutics, 17(6), 1848–1858. https://doi.org/10.1021/acs.molpharmaceut.9b01213

Chicago

Gallego, Idoia, Ilia Villate-Beitia, Cristina Soto-Sánchez, Margarita Menéndez, Santiago Grijalvo, Ramón Eritja, Gema Martínez-Navarrete, et al. 2020. “Brain Angiogenesis Induced by Nonviral Gene Therapy with Potential Therapeutic Benefits for Central Nervous System Diseases.” Molecular Pharmaceutics 17 (6): 1848–58. doi:10.1021/acs.molpharmaceut.9b01213.